Thomas J. Dilling
Moffitt Cancer Center · 206 works · 10,644 citations · h-index 34
Top works
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
- Treatment of Stage III Non-small Cell Lung Cancer
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
- Non–Small Cell Lung Cancer, Version 4.2024
- Non–Small Cell Lung Cancer, Version 6.2015
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
- NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
- Non–Small Cell Lung Cancer, Version 1.2015
- Clinical and Dosimetric Predictors of Radiation Pneumonitis in a Large Series of Patients Treated With Stereotactic Body Radiation Therapy to the Lung
- Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung Cancer
- Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique
- Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
- Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases
- Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study
- Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments
- CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy
- Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer